🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Investigational Treatment Gaining Popularity Via Social Media

Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged fat-burning effects. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with thousands of participants share “before and after” images, administration instructions and assertions of next-day British shipping. Vendors promote the substance there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Express Worries

However, doctors and pharmacists have warned that the distribution of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals injecting products of unknown origin.

Several experts stated the demand for the experimental drug could be connected to the rising price of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and customer laws, risking penalties, legal action or imprisonment.

Platform Reaction and Content Removal

Based on TikTok, the platform has taken down problematic material and banned associated keywords and query recommendations. The organization stated it was dedicated to keeping the service safe and investing in strengthening compliance measures.

Digital Trading Activities

Investigations also found groups with up to 9,000 participants selling retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of users, filled with images of slimming results, glowing testimonials and detailed instructions for mixing or administering at home.

After minutes of entering one community, a seller posted WhatsApp details, where most transactions take place. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, health issues or past usage.

Item Information and Costs

Within these communities, posts display black plastic packages with postal service labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually priced at £160 for 20 milligrams. When asked how long a injector should last, vendors give contradictory responses varying between a several days to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service stated it actively monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they can’t verify. Although the science behind this drug is valid, these online versions may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are using social media. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her staff has previously seen patients injured by personal administration from unverified sources. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company experimental product not yet approved … may subject patients to possibly serious health risks”.